Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$7.02 USD
-0.32 (-4.36%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $7.01 -0.01 (-0.14%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 39% (154 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.63 | 1.52 | 9.99 |
Current Quarter Estimate | -0.35 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.38 | -0.59 | 54.84 |
Next Quarter Estimate | -0.33 | -2.00 | 63.00 |
Next Year Estimate | -1.36 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 1.27 | 14.00 | 15.67 |
Next Year | 12.82 | 16.30 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 24.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 4.16 | 1.84 |
Price/Cash Flow (MRFY) | NA | 8.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -765.90% | -13.40% |
Return on Equity (TTM) | -79.96% | -71.77% |
Debt to Equity (MRQ) | NA | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.